ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979

DCT Board Okays Six Contract Recompetitions

October 23, 1987

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

Vogel To Succeed Yates As VP for Research At American Cancer Society.

October 17, 2008

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978